1 bi o medical designs provides smart catheter solutions january 2012

16
1 Bi Bi o o medical medical Designs Designs Provides Provides Smart Catheter Solutions Smart Catheter Solutions January 2012

Upload: naomi-hampton

Post on 02-Jan-2016

213 views

Category:

Documents


0 download

TRANSCRIPT

11

BiBi oo medical Designsmedical DesignsProvides Provides

Smart Catheter SolutionsSmart Catheter Solutions

January 2012

22

Clinician’s PainClinician’s Pain

ProblemProblem SolutionSolutionIncorrect Catheter Placement Rapid and Sure Placement

Catheter Migration Location Monitoring

No Preliminary Diagnostics Integrated Diagnostic MicroSensors

BI O MEDICAL DESIGNS

33

Societal Impact and Consequences of Endotracheal Societal Impact and Consequences of Endotracheal Tubes (ETT) and Nasogastric Tubes (NGT) Tubes (ETT) and Nasogastric Tubes (NGT)

Misplacement and Lack of MonitoringMisplacement and Lack of Monitoring

ETT- 350,000 annual cases of Ventilator Acquired Pneumonia - Cost $3.0 billion.

NGT - 65,000 annual cases of aspirated pneumonia (following abdominal surgery) - Cost $2.0 billion.

BI O MEDICAL DESIGNS

44

Societal Impact and Consequences of ETT Societal Impact and Consequences of ETT and NGT Misplacement and Lack of and NGT Misplacement and Lack of

Monitoring - IIMonitoring - II

>$100 million annual Lawsuits from misplaced or migrating NGT or ETT that lead to either severe injury or death.

The “gold standard” x-ray to confirm NGT placement - That provides only a “ momentary snap shot” - Cost $62.5 million annually.

ETT x-ray “momentary snap shots” - Annual cost $600 million.

Misinterpretation of x-rays taken is another issue with an unknown cost.

BI O MEDICAL DESIGNS

55

The Solution: SmartCathThe Solution: SmartCath

Nasogastric tubes ( NGT)

Endotracheal tubes (ETT)

BI O MEDICAL DESIGNS

66

NG-ET Optimizer TechnologyNG-ET Optimizer Technology

Base unit with DisplayBase unit with Display

Encapsulated RFID & Encapsulated RFID &

Sensors for NGT or ETT tip Sensors for NGT or ETT tip

A Reader to send key health parametersA Reader to send key health parameters

to the Base unit for interpretation to the Base unit for interpretation

and display.and display.

BI O MEDICAL DESIGNS

77

SmartCath SystemSmartCath SystemReplaces multiple ineffective Replaces multiple ineffective

position techniques, provides ongoing monitoring and display of position techniques, provides ongoing monitoring and display of key health parameterskey health parameters

88

Biomedical Designs Developmental Timelines Biomedical Designs Developmental Timelines Conforming to FDA and Industry RequirementsConforming to FDA and Industry Requirements

Stages of Stages of Development Development

Process:Process:

Catheter Catheter developmentdevelopment

ElectronicElectronic

UnitUnit

DevelopmentDevelopment

Regulatory Regulatory submissionsubmission

Proof of Proof of concept for concept for

IndustryIndustry

DeliverableDeliverable

Sensorized Sensorized Nasogastric , Nasogastric , Endotracheal Endotracheal

CathetersCatheters

Catheter Catheter integration integration

developmentdevelopment

FDA regulatory FDA regulatory process during process during development development

cyclecycle

Design Design production of production of catheters and catheters and

systems/systems/

conduct clinical conduct clinical testingtesting

Cost Cost $450k$450k $950k$950k $30$30 $1.9$1.9

TimingTiming

9 months9 months

(in conjunction (in conjunction with electronic with electronic

system system development)development)

9 months ( in 9 months ( in conjunction conjunction

with catheter with catheter development)development)

Conducted Conducted during catheter during catheter

system system developmentdevelopment

12 months12 months

ProviderProvider Bit- MedTech Bit- MedTech Bit-MedTechBit-MedTech AlquestAlquest Hospital Hospital Surgical units Surgical units

and ICU’sand ICU’s

BI O MEDICAL DESIGNS

99

Projected NGT SalesProjected NGT Sales

BI O MEDICAL DESIGNS

1010

Projected ETT SalesProjected ETT Sales

BI O MEDICAL DESIGNS

1111

Biomedical Designs Key PersonnelBiomedical Designs Key Personnel

Suzanne BiddiscombeSuzanne Biddiscombe, B.A., M.A., CEO – 20 years in sales and marketing. , B.A., M.A., CEO – 20 years in sales and marketing. Responsible for the day to day operations of Biomedical Designs, specifically Responsible for the day to day operations of Biomedical Designs, specifically research, business plan development, marketing and sales.research, business plan development, marketing and sales.

• David Decker David Decker – CFO; President of Personnel Communications. A highly – CFO; President of Personnel Communications. A highly successful entrepreneur in multiple fields. Provided capital to develop the two successful entrepreneur in multiple fields. Provided capital to develop the two prototype base units that comprise the SmartCath System.prototype base units that comprise the SmartCath System.

• Dr. Jimmie Spraker, Jr. CSO; Dr. Jimmie Spraker, Jr. CSO; PhD, EE – Co-inventor of technology. 25 years PhD, EE – Co-inventor of technology. 25 years experience in hardware and software development and engineering. Jimmie’s experience in hardware and software development and engineering. Jimmie’s entire 30 year career has been dedicated to the advancement of the entire 30 year career has been dedicated to the advancement of the biotechnology field.biotechnology field.

BI O MEDICAL DESIGNS

1212

Biomedical Designs Key PersonnelBiomedical Designs Key Personnel

Kim Chaffee- B.S. E.M.T – Director of Smith’s Medical North American Division of Kim Chaffee- B.S. E.M.T – Director of Smith’s Medical North American Division of Anesthesiology . Kim has been with Smith’s Medical for 15 years and has extensive Anesthesiology . Kim has been with Smith’s Medical for 15 years and has extensive knowledge of the respiratory care arena within the hospital environment. She knowledge of the respiratory care arena within the hospital environment. She oversees Smith’s Respiratory marketing team within the United States.oversees Smith’s Respiratory marketing team within the United States.

C. William King C. William King – BSEE, MBA , CEO and President of Essential Research, Inc., A – BSEE, MBA , CEO and President of Essential Research, Inc., A high tech entrepreneur with experience in four startups since 1998. Bringing more high tech entrepreneur with experience in four startups since 1998. Bringing more than 50 new products to the market with a cumulative value >$250 million, including than 50 new products to the market with a cumulative value >$250 million, including >12 new products requiring 510 k approval.>12 new products requiring 510 k approval.

Patty Kelly Patty Kelly – A registered nurse with over 25 years of experience working in Hospital – A registered nurse with over 25 years of experience working in Hospital ICU’s. Consulted during the development of the two prototype units.ICU’s. Consulted during the development of the two prototype units.

Dr. Sandra Perez-SprakerDr. Sandra Perez-Spraker, MD, RN. Worked for over 10 years in ICU’s and ER’s. , MD, RN. Worked for over 10 years in ICU’s and ER’s. Consulted during the development of two prototype units.Consulted during the development of two prototype units.

BI O MEDICAL DESIGNS

1313

Intellectual Property StatusIntellectual Property Status

All Patent Filings are Pending: Filing Date Nasogastric Placement and Monitoring System May 2007 Medical Device Placement and Monitoring Device Utilizing Radio Frequency Identification July 2009

BI O MEDICAL DESIGNS

1414

Capital RequiredCapital Required

Biomedical Designs, LLC has raised and invested $500K to date

Clinical Testing and FDA approval are the next significant inflection points

Amount: $4,500,000 to complete Structure: Percentage of return based upon

Investment Timing: Spring 2012

BI O MEDICAL DESIGNS

1515

Exit StrategyExit StrategyBiomedical Designs, LLC is a catheter development oriented company, with these key objectives:

Be a research oriented company advancing numerous proprietary catheter technologies to engage designed electronics.

Within 24 months complete technology, testing and FDA approval.

Within 30 months return the principal of investments plus percentage on sale of technology.

Create liquidity through sale of completed technology to tube manufacturer, medical device manufacturer, or recognized industry leader in respiratory care or equivalent.

BI O MEDICAL DESIGNS

1616

Contact InformationContact Information

Suzanne M. Biddiscombe, CEOSuzanne M. Biddiscombe, CEO Phone: 678-794-5657Phone: 678-794-5657 e-mail: [email protected]: [email protected] website: www.biomedicaldesigns.comwebsite: www.biomedicaldesigns.com Video Demonstration available

BI O MEDICAL DESIGNS